Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02779803Withdrawn

STAMCAR: A Prospective EC-IC Bypass Registry

Role: collaborator

NCT00447343Completed

Reorganization of Brain Functions in Patients With Cervical Myelopathy Using fMRI and MRS

Role: collaborator

NCT01220921Phase 3Completed

Neurosurgery Patient Outcomes in Treating Spinal Disorders

Role: collaborator

NCT00559494Phase 1Completed

Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury

Role: collaborator

NCT00233701Completed

Normal Pressure Hydrocephalus (NPH) Registry

Role: collaborator

All 5 trials loaded